Behcet's ileocolitis: Successful treatment with tumor necrosis factor-alpha antibody (infliximab) therapy - Report of a case

被引：51
|
作者：
Kram, MT [1 ]
May, LD [1 ]
Goodman, S [1 ]
Molinas, S [1 ]
机构：
[1] Nyack Hosp, Dept Gastroenterol, Nyack, NY USA
来源：
DISEASES OF THE COLON & RECTUM | 2003年 / 46卷 / 01期
关键词：
antibodies; monoclonal/therapeutic use; Behcet's syndrome; Behcet's syndrome/diagnosis; Behcet's syndrome/drug therapy; Behcet's syndrome/pathology; Behcet's syndrome/surgery; tumor necrosis factor;
D O I：
10.1007/s10350-004-6506-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Behcet's disease is a chronic inflammatory disease characterized by recurrent oral aphthae and systemic manifestations. Gastrointestinal involvement is rare. We report a case of ileocolitis secondary to Behcet's successfully treated with tumor necrosis factor-alpha antibody (infliximab) therapy. To our knowledge this is the second reported case of Behcet's ileocolitis successfully treated with anti-tumor necrosis factor therapy.
引用
收藏
页码：118 / 121
页数：4
相关论文
共 50 条
  • [21] Infection and anti-tumor necrosis factor-alpha therapy
    Zandman-Goddard, G
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2003, 5 (11): : 814 - 816
  • [22] Prostatic Abscesses in a Patient Receiving Tumor Necrosis Factor-Alpha Inhibitor Therapy for Hidradenitis Suppurativa: A Case Report
    Lautenschlager, Severin
    Strebel, Rato
    Ahmadi, Khosrow
    Birzele, Jan
    Gu, Alexander
    Nowag, Anna
    Scherer, Thomas
    Bieri, Uwe
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [23] Successful IV infusion of anti tumor necrosis factor alpha (infliximab) therapy in a pediatric office setting
    Cohen, SA
    Saripkin, CJ
    Saripkin, LM
    Pilzer, ES
    Blumenthal, JA
    Sherrod, OM
    Meyers, WF
    Hochman, JA
    Lewis, JD
    Hopkins, KT
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S257 - S258
  • [24] Severe lupus induced by the tumor necrosis factor-alpha inhibitor Anbainuo: a case report
    Pan, Xiaoli
    Yuan, Yuan
    Huang, Fei
    Tian, Mei
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (06)
  • [25] Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor α monoclonal antibody infliximab
    Brandt, J
    Haibel, H
    Cornely, D
    Golder, W
    Gonzalez, J
    Reddig, J
    Thriene, W
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2000, 43 (06): : 1346 - 1352
  • [26] Treatment of Hidradenitis Suppurativa with Tumour Necrosis Factor-alpha Inhibitors: An Update on Infliximab
    Brunasso, Alexandra Maria Giovanna
    Massone, Cesare
    ACTA DERMATO-VENEREOLOGICA, 2011, 91 (01) : 70 - 71
  • [27] A single infusion of the tumor necrosis factor-alpha antibody infliximab suppresses bone resorption in patients with rheumatoid arthritis.
    Dimai, HP
    Mueller, T
    Fahrleitner, A
    Hermann, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S274 - S275
  • [28] Fish tank granuloma during tumor necrosis factor-alpha inhibitor treatment: A case report and literature review
    Berman, Hannah S.
    Thomas, Logan
    Beynet, David
    Gates, Gregory
    Shi, Vivian
    Hsiao, Jennifer
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [29] Successful management of tumor necrosis factor-alpha inhibitor-induced Sweet syndrome in a patient with ulcerative colitis: A case report
    Chang, Yung-Chun
    Yang, Hui-Ju
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2022, 60 (01) : 46 - 51
  • [30] Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behcet's disease
    Ates, A
    Kinikli, G
    Düzgün, N
    Duman, M
    RHEUMATOLOGY INTERNATIONAL, 2006, 26 (04) : 348 - 353
12345